In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, discusses small-molecule APIs, excipients, and formulation advances, including a discussion about novel approaches and solutions to pediatric formulations and taste-masking, a rundown of the fundamental stages of gaining a certificate of suitability for APIs, and a deliberation on the biggest trends impacting the industry and key sessions to visit while at CPHI, with several key industry experts.
In this exclusive Drug Digest video interview, Felicity Thomas, European/Senior Editor, Pharmaceutical Technology Group, interviews experts about small-molecule APIs, excipients, and formulation advances. During the video session, a panel of experts—Bikash Chatterjee, Tara Dougal, Sean Daughtry, and Ramesh Subramanian—deliberate on the biggest trends impacting the industry, highlighting issues such as API supply and shortages, uptake in digital innovations, formulation advances to deal with potent compounds, and key sessions to visit while at CPHI. Additionally, David Tisi, director of Technical Operations, Senopsys, discusses novel approaches and solutions to pediatric formulations and taste-masking, while an expert Tara Fitzpatrick from C2 Pharma highlights the fundamental stages of gaining a certificate of suitability for APIs and the various trends shaping API and complex compound manufacturing.
David Tisi, Director of Technical Operations, Senopsys
Tara Fitzpatrick, Head of Quality, C2 Pharma
Bikash Chatterjee, President and Chief Science Officer at PharmaTech Associates
Tara Dougal, Content Director—Pharma, Informa Markets
Sean K. Daughtry, Director of Technical Operations Analytical, CMSC Strategic Product Lead—AMKD, Vertex Pharmaceuticals
Ramesh Subramanian, Chief Commercial Officer, Aragen Life Sciences
This episode of Drug Digest is sponsored by:
Drug Digest is a tech talk video series with the Pharmaceutical Technology editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.